Trigger Finger
Conditions
Keywords
Trigger finger, Hyaluronic Acid, Corticosteroid, Ultrasound-guided injection
Brief summary
The aim of the study is to compare the therapeutic effects of hyaluronic acid versus steroid injections in treating trigger fingers using ultrasound guidance
Detailed description
A prospective randomized controlled study designed to compare the outcomes of injecting patients with trigger finger with hyaluronic acid versus corticosteroid under ultrasound guidance
Interventions
DRUGhyaluronic acid (20 mg/2 mL)
A1-Pulley infiltration for trigger finger
A1-Pulley infiltration for trigger finger
Sponsors
Dubai Health Authority
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult (\>18 years) * Patients with a clinical diagnosis of trigger finger grade 1-3 on the Quinnell grading scale and confirmed diagnosis by ultrasound.
Exclusion criteria
* Quinnell's classification grade IV (contracture) * Prior injection within 6 months * Prior operation of the affected finger * Presence of any contracture in the proximal interphalangeal or metacarpophalangeal joint, and * History of diabetes, hypothyroidism, and * Rheumatic or connective tissue disease * Allergy to triamcinolone or hyaluronic acid * Pregnancy * Secondary triggering e.g. Trauma, infection * Trigger finger symptoms duration \>6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Quinnell trigger finger grading system: | 1 and 3 months post-injection | Change in Quinnell grading overtime within 3 months after injection. Trigger fingers are rated as follows: Grade 0: normal finger movements, Grade 1: uneven finger movements, Grade 2: actively correctable triggering, Grade 3: passively correctable triggering, and Grade 4: locked digit. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Frequency of tender trigger nodules | 1 and 3 months post-injection | Identifying the presence of tender nodules at A1-pulley of the affected finger by palpation |
| The Quick Disability of the Arm, Shoulder and Hand score | 1 and 3 months post-injection | Patients will be asked to fill a questionnaire form. It is an 11-item form that assesses the upper limb function on a scale of 1-5, with scores ranging from 11 to 55, with the higher scores representing more disability and worse upper limb function. |
| Visual analogue scale (VAS) of pain | 1 and 3 months post-injection | Change in pain Visual analogue scale will be recorded. The patient marks on the 100 mm in length line the point that he/she feels to represent his/her perception of pain at the current state. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks ( a higher score indicates greater pain intensity). Categorization of none, mild, moderate and severe pain will be also used (none = 0, mild = 1-4, moderate = 5-6, and severe = 7-10). |
| Patient satisfaction with therapy | 1 and 3 months post-injection | Participating patients will be asked to classify their result into 1 of 4 categories: (1) complete resolution of symptoms, (2) improved result, but incomplete resolution of symptoms, not warranting further treatment, (3) partial response, but unsatisfactory, warranting further treatment, and (4) no response. |
| Ultrasound evaluation of A1-Pulley | 1 and 3 months post-injection | Detailed ultrasonography evaluation of A1-Pulley. Comparing the A1-Pulley ultrasonographic parameters over 3 months after injection (at the follow-up appointment) |
| Changes in Grip strength | 1 and 3 months post-injection | Measured by the dynamometer strength test (Jamar grip dynamometer) |
Countries
United Arab Emirates
Contacts
Primary ContactSahar S Khalil, SSR
Backup ContactMohamed M Abdulla, Consultant
Outcome results
None listed